|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61P 1/02 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 9/04 | (2018.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 5/14 | (2018.01) | ||
| A61K 38/06 | (2013.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/10 | (2018.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 9/12 | (2018.01) | ||
| A61P 25/30 | (2018.01) | ||
| A61P 25/32 | (2018.01) |
| (11) | Number of the document | 3586862 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19185584.0 |
| Date of filing the European patent application | 2013-10-22 | |
| (97) | Date of publication of the European application | 2020-01-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-08 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261716867 P | 2012-10-22 | US | |
| 201361822752 P | 2013-05-13 | US | |
| 201361839743 P | 2013-06-26 | US | |
| 201361839750 P | 2013-06-26 | US |
| (72) |
WILSON, D. Travis , US
SABBAH, Hani N. , US
|
| (73) |
Stealth Peptides International, Inc. ,
2nd Floor Le Prince de Galles
3-5 Avenue des Citronniers, 98000 Monaco,
MC
Henry Ford Health Systems , 2799 West Grand Boulevard, Detroit, MI 48202, US |
| (54) | METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH |
| METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH |